Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-093035

Chief Medical Officer sold 781 shares at $5.04 ($3,936)

  • Chief Medical Officer acquired 781 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nichols William Garrett · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-30 Exercise or conversion : show line 1 in the form 10b5-1 +781 $1.29 $1,007 53,274 D
2025-06-30 Sale : show line 2 in the form 10b5-1 −781 $5.04 $3,936 52,493 D
Open-market sales · 781 sh · avg $5.04 · $3,936

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-30 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −781 30,314 D
Loading xslF345X05/ownership.xml…